Winning Stock Forecast: ENDP Returns up to 30.67% in 1 Month with global expansion and counter lawsuits
“One of the biggest challenges to medicine is the incorporation of information technology in our practices.”
– Samuel Wilson
(Source: Air Force Medical Service)
Endo International plc, incorporated on October 31, 2013, is a generics and specialty branded pharmaceutical company. The company has three segments: U.S. Generic Pharmaceuticals, U.S. Branded Pharmaceuticals and International Pharmaceuticals. It has its own brand names and its non-branded U.S. Generic Pharmaceuticals portfolio consists of products, such as tablets, capsules, powders, injectables, liquids, nasal sprays, ophthalmics
